Pune-based Serum Institute of India (SII) announced a strategic investment in IntegriMedical, based in Bainbridge, IN. where SII will acquire a 20% stake in the company. This partnership aims to advance IntegriMedical's Needle-Free Injection System (N-FIS) technology, aligning with SII's vision of 'Health for All' and IntegriMedical's mission to 'Transform...
India’s Serum Institute Invests in Oxford Biomedica Plc
Pune, Maharshtra-based Serum Institute of India (SII) invested over $68 million in UK-based Oxford Biomedica plc, a gene and cell therapy company specializing in the development of gene-based medicines. Serum Life Sciences Ltd, a unit of SII, will pick up a 3.9% stake in Oxford Biomedica as part of the...
India’s Serum Institute Supplies Covovax to U.S, Malaria Vaccines to U.K.
Earlier this year., India's Drugs Controller General granted permission to Pune Maharashtra-based Serum Institute of India to supply over 32,000 doses of its COVID-19 jab Covovax under the brand name Nuvaxovid to the U.S. Covovax is manufactured through technology transfer from Novavax, an American Company and is approved by the...
Serum Institute of India to Stockpile Vaccines for the World
On the outskirts of Pune, in India's western state of Maharashtra, at the 100-acre campus of Serum Institute of India (SII), CEO Adar Poonawalla proposes to set up a plug-and-play vaccine-making facility in preparation for the next pandemic. Since the facility can handle all different technologies, Poonawalla has offered 300,000 sq...
India’s Serum Institute Manufactures Vaccines for U.S. Government
Following on an approval from the USFDA, Gaithersburg, Maryland-based biotechnology company Novavax said that its Covid-19 vaccine Nuvaxovid for adults will be manufactured by its partner Serum Institute of India. (SII) "It is the first vaccine from India to be approved by the USFDA," Serum Institute’s CEO Adar Poonawalla, said....
Intranasal Vaccines Can Protect against Covid 19 Pathogens
Nasal vaccines, or more accurately known as intranasal vaccines, can protect against airborne pathogens that enter through the nose causing the flu or the coronavirus. Research shows that delivering the vaccine directly to the mucosa might be a better approach for preventing Covid infection. Mayuresh Abhyankar, a researcher at the...